NAFDAC RECALLS MALE ENHANCEMENT SUPPLEMENT, WARNS PUBLIC AGAINST USE
Read Time:1 Minute, 43 Second
By ‘Sefiu Ajape
The National Agency for Food and Drug Administration and Control has announced a voluntary recall of all batches of the male enhancement dietary supplement MR.7 SUPER 700000 capsules, citing serious safety concerns.
In a notice posted on its X handle on Monday, the agency said the recall followed an analysis by the U.S. Food and Drug Administration which found that the product contains undeclared active ingredients—Sildenafil and Tadalafil.
“Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors found in FDA-approved products for the treatment of male erectile dysfunction.
“The presence of sildenafil and tadalafil in ‘MR.7 SUPER 700000’ capsules renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall.
READ MORE :
MICHAEL B. JORDAN WINS BEST ACTOR OSCAR FOR ‘SINNERS’ (PHOTOS)
“MR.7 SUPER 700000 capsules are marketed online as a dietary supplement for male enhancement. Products containing sildenafil or tadalafil cannot be marketed as dietary supplements and could cause serious health risks,” NAFDAC warned.
“The presence of these undeclared ingredients renders the capsules unapproved drugs for which safety and efficacy have not been established, and therefore they are subject to recall,” it added.
The agency explained that the consumption of such products could dangerously interact with nitrates found in certain prescription medications, including nitroglycerin, potentially leading to a life-threatening drop in blood pressure.
It further warned that adult males suffering from diabetes, high blood pressure, high cholesterol, or heart disease who take nitrate-based medications face the highest risk.
NAFDAC advised the public to immediately stop using or selling MR.7 SUPER 700000 capsules and to return any remaining stock to the nearest NAFDAC office.
The agency also urged consumers to report compromised products or adverse reactions linked to medicinal products or medical devices through its e-reporting platforms, the Med-safety app, or via official email channels.
NAFDAC reaffirmed its commitment to protecting public health through continued monitoring and regulation of medicines, medical devices and other products circulating in Nigeria.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0